| 11/13/2026 7:51 AM | AQR CAPITAL MANAGEMENT LLC (1167557) Filed by Ultragenyx Pharmaceutical (1515673) Subject | Form SCHEDULE 13G/A | |
| 11/10/2026 8:29 AM | STATE STREET CORP (93751) Filed by STATE STREET CORP (93751) Filed by Ultragenyx Pharmaceutical (1515673) Subject | Form SCHEDULE 13G | |
| 11/03/2026 3:07 PM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2026 1:14 PM | Ultragenyx Pharmaceutical (1515673) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G/A | |
| 10/20/2026 4:37 PM | Madison Avenue Partners, LP (1801265) Filed by Ultragenyx Pharmaceutical (1515673) Subject | Form SCHEDULE 13G | |
| 10/19/2026 12:48 PM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/19/2026 8:00 AM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/14/2026 8:00 AM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/07/2026 8:00 AM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/15/2026 5:57 PM | Huizenga Theodore Alan (1603347) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 3:33 PM | Huizenga Theodore Alan (1603347) Reporting Ultragenyx Pharmaceutical (1515673) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for RARE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ultragenyx Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/08/2026 11:29 AM | Huizenga Theodore Alan (1603347) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/19/2026 4:24 PM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2026 7:15 AM | RTW INVESTMENTS, LP (1493215) Filed by Ultragenyx Pharmaceutical (1515673) Subject | Form SCHEDULE 13G | |
| 08/11/2026 7:30 AM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/07/2026 10:05 AM | STATE STREET CORP (93751) Filed by STATE STREET CORP (93751) Filed by Ultragenyx Pharmaceutical (1515673) Subject | Form SCHEDULE 13G | |
| 08/04/2026 2:13 PM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/04/2026 2:15 PM | Parschauer Karah Herdman (1677455) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/03/2026 3:18 PM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/31/2026 10:40 AM | Ultragenyx Pharmaceutical (1515673) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G/A | |
| 07/31/2026 9:46 AM | Ultragenyx Pharmaceutical (1515673) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 07/30/2026 10:18 AM | BlackRock, Inc. (2012383) Filed by Ultragenyx Pharmaceutical (1515673) Subject | Form SCHEDULE 13G/A | |
| 07/06/2026 2:37 PM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 3:19 PM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/15/2026 5:46 PM | Parschauer Karah Herdman (1677455) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 5:50 PM | Sanders Corazon (0) Corsee Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 3:50 PM | Parschauer Karah Herdman (1677455) Reporting Ultragenyx Pharmaceutical (1515673) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/12/2026 12:40 PM | Ultragenyx Pharmaceutical (1515673) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 06/01/2026 6:11 PM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 5:38 PM | Sanders Corazon (0) Corsee Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 5:39 PM | Ray Amrit (1924797) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 5:41 PM | SULIMAN SHEHNAAZ (1713070) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 5:50 PM | Fust Matthew K (1397266) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 5:23 PM | Ultragenyx Pharmaceutical (1515673) Issuer WELCH DANIEL G (1206199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 5:35 PM | NARACHI MICHAEL (1380022) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 5:21 PM | Dunsire Deborah (1332764) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:50 PM | SULIMAN SHEHNAAZ (1713070) Reporting Ultragenyx Pharmaceutical (1515673) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/18/2026 1:15 PM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/12/2026 11:12 AM | STATE STREET CORP (93751) Filed by STATE STREET CORP (93751) Filed by Ultragenyx Pharmaceutical (1515673) Subject | Form SCHEDULE 13G | |
| 05/06/2026 1:51 PM | Crombez Eric (1653052) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 3:06 PM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Drop these 5 stocks before the market opens tomorrow! (Ad) The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks.
A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out. See the five stocks Weiss Ratings analysts are watching closely now. |
| 05/04/2026 4:35 PM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 3:06 PM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/29/2026 2:48 PM | Ultragenyx Pharmaceutical (1515673) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
| 04/24/2026 3:39 PM | Huizenga Theodore Alan (1603347) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 4:09 PM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 4:11 PM | Crombez Eric (1653052) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 4:13 PM | Harris Erik (1780113) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 4:15 PM | Parschauer Karah Herdman (1677455) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 4:16 PM | Pinion John Richard (1648096) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 4:17 PM | Huang Dennis Karl (1641217) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 4:19 PM | KAKKIS EMIL D (1248093) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 5:19 PM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 7:45 AM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/01/2026 3:12 PM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/30/2026 7:45 AM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/27/2026 3:30 PM | Ultragenyx Pharmaceutical (1515673) Filer | Form DEF 14A | |
| 03/27/2026 3:30 PM | Ultragenyx Pharmaceutical (1515673) Filer | Form DEFA14A | |
| 03/27/2026 3:31 PM | Ultragenyx Pharmaceutical (1515673) Filer | Form ARS | |
| 03/27/2026 12:54 PM | Ultragenyx Pharmaceutical (1515673) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/12/2026 7:45 AM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/06/2026 4:28 PM | Parschauer Karah Herdman (1677455) Reporting Ultragenyx Pharmaceutical (1515673) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/03/2026 6:06 PM | KAKKIS EMIL D (1248093) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 6:08 PM | Harris Erik (1780113) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 6:09 PM | Pinion John Richard (1648096) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 5:51 PM | Huizenga Theodore Alan (1603347) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 5:51 PM | Parschauer Karah Herdman (1677455) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 5:49 PM | Huang Dennis Karl (1641217) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 5:49 PM | Crombez Eric (1653052) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 5:50 PM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 4:08 PM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/23/2026 7:45 AM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/05/2026 12:40 PM | FMR LLC (315066) Filed by Ultragenyx Pharmaceutical (1515673) Subject | Form SCHEDULE 13G/A | |
| 02/03/2026 11:00 AM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 7:15 AM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/02/2026 3:09 PM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/30/2026 7:45 AM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/12/2026 6:45 AM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/05/2026 3:07 PM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/02/2026 3:10 PM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/30/2025 3:11 PM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/30/2025 12:49 PM | Huizenga Theodore Alan (1603347) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/29/2025 7:45 AM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/29/2025 7:45 AM | Ultragenyx Pharmaceutical (1515673) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/11/2025 11:10 AM | Horn Howard (1786335) Reporting Ultragenyx Pharmaceutical (1515673) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |